Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urine DNA biomarkers for hepatocellular carcinoma screening
Amy K. Kim, James P. Hamilton, Selena Y. Lin, et al.
British Journal of Cancer (2022) Vol. 126, Iss. 10, pp. 1432-1438
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Risk stratification and early detection biomarkers for precision HCC screening
Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (2022), pp. n/a-n/a
Open Access | Times Cited: 60
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
Zishuai Li, Zihan Zhang, Letian Fang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2083-2099
Open Access | Times Cited: 18
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Novel Biomarkers for Early Detection of Hepatocellular Carcinoma
Abdelrahman M. Attia, Mohammad Saeid Rezaee‐Zavareh, Soo Young Hwang, et al.
Diagnostics (2024) Vol. 14, Iss. 20, pp. 2278-2278
Open Access | Times Cited: 5
Circulating Biomarkers for the Early Diagnosis and Management of Hepatocellular Carcinoma with Potential Application in Resource-Limited Settings
Annabelle Pan, Thai N. Truong, Ying‐Hsiu Su, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 676-676
Open Access | Times Cited: 13
Transforming Disease Diagnosis and Management: A Comprehensive Review of AI-Driven Urine Analysis in Clinical Medicine
Vinod Kumar Shukla, Manu Sudhi, Dasharathraj K Shetty, et al.
Engineered Science (2023)
Open Access | Times Cited: 11
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
Chromatin accessibility states affect transrenal clearance of plasma DNA: Implications for urine-based diagnostics
L Mary-Jane, Woody Z Zhang, Peiyong Jiang, et al.
Med (2025), pp. 100646-100646
Open Access
New insights into biomarkers and risk stratification to predict hepatocellular cancer
Kechun Li, Bino Mathew, Erick Figueiredo Saldanha, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers
Michael S. Lee, Ahmed O. Kaseb, Shubham Pant
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3267-3274
Closed Access | Times Cited: 10
Liquid-based biomarkers in breast cancer: looking beyond the blood
You Shuai, Zhonghua Ma, Jie Ju, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Advances in application of serum biomarkers for screening and early diagnosis of hepatocellular carcinoma
Zihan Liu, Juanjuan Shi, Meng Zhang, et al.
Shijie huaren xiaohua zazhi (2025) Vol. 33, Iss. 4, pp. 251-260
Open Access
Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma
Eun Ju Cho, Boram Kim, Su Jong Yu, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 6, pp. 970-975
Open Access | Times Cited: 2
Moving Forward Liquid Biopsy in Early Liver Cancer Detection
Christian Rolfo, Alessandro Russo
Cancer Discovery (2023) Vol. 13, Iss. 3, pp. 532-534
Open Access | Times Cited: 5
Novel urine cell-free DNA methylation markers for hepatocellular carcinoma
Selena Y. Lin, Wei Xia, Amy K. Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
Selena Y. Lin, Dina Halegoua‐De Marzio, Peter D. Block, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1537-1537
Open Access | Times Cited: 4
Impact of Cell-Debris and Room-Temperature Storage on Urine Circulating Tumor DNA from Hepatocellular Carcinoma
Amy K. Kim, Selena Y. Lin, Zhili Wang, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 12, pp. 913-920
Open Access | Times Cited: 4
Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
Kaige Deng, Jiali Xing, Gang Xu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer
Rui Wang, Yue Yang, Tianyu Lu, et al.
PeerJ (2024) Vol. 12, pp. e16802-e16802
Open Access | Times Cited: 1
Detection of hepatocellular carcinoma methylation markers in salivary DNA
Catherine Mezzacappa, Zhanwei Wang, Lingeng Lu, et al.
Bioscience Reports (2024) Vol. 44, Iss. 3
Open Access | Times Cited: 1
Advancements in bladder cancer detection: a comprehensive review on liquid biopsy and cell-free DNA analysis
Indraneel Rakshit, Sudeshna Mandal, Sreejit Pal, et al.
The Nucleus (2024)
Closed Access | Times Cited: 1
Systematic pan-cancer analysis identified RASSF1 as an immunological and prognostic biomarker and validated in lung cancer
Yibing Bai, Yuanyong Wang, Jiapei Qin, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33304-e33304
Open Access | Times Cited: 1
Microfluidics‐Based Urine Biopsy for Cancer Diagnosis: Recent Advances and Future Trends
Yanping Wang, Yanfeng Gao, Yujun Song
ChemMedChem (2022) Vol. 17, Iss. 20
Closed Access | Times Cited: 7
Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C Virus
Alessio Aghemo, Davide Polverini, Massimo Colombo
Current Hepatology Reports (2024) Vol. 23, Iss. 3, pp. 364-372
Closed Access
Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions
Noah X. Tocci, Chase J. Wehrle, Keyue Sun, et al.
Journal of Surgical Oncology (2024)
Open Access
Page 1 - Next Page

Scroll to top